Loading...

Daniel M. Togasaki, MD, PhD

Title(s)Associate Professor of Clinical Neurology
AddressHCT 3000
Health Sciences Campus
Los Angeles CA 90089
Phone+1 323 442 5728
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Websites

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Dextromethorphan/Quinidine in Migraine Prophylaxis: An Open-label Observational Clinical Study. Clin Neuropharmacol. 2018 Mar/Apr; 41(2):64-69. Berkovich RR, Sokolov AY, Togasaki DM, Yakupova AA, Cesar PH, Sahai-Srivastava S. PMID: 29474194.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. CD4 cell response to interval therapy with natalizumab. Ann Clin Transl Neurol. 2015 May; 2(5):570-4. Berkovich R, Togasaki DM, Cen SY, Steinman L. PMID: 26000328.
      View in: PubMed   Mentions: 1     Fields:    
    3. Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial. JAMA Neurol. 2014 Feb; 71(2):141-50. Schwarzschild MA, Ascherio A, Beal MF, Cudkowicz ME, Curhan GC, Hare JM, Hooper DC, Kieburtz KD, Macklin EA, Oakes D, Rudolph A, Shoulson I, Tennis MK, Espay AJ, Gartner M, Hung A, Bwala G, Lenehan R, Encarnacion E, Ainslie M, Castillo R, Togasaki D, Barles G, Friedman JH, Niles L, Carter JH, Murray M, Goetz CG, Jaglin J, Ahmed A, Russell DS, Cotto C, Goudreau JL, Russell D, Parashos SA, Ede P, Saint-Hilaire MH, Thomas CA, James R, Stacy MA, Johnson J, Gauger L, Antonelle de Marcaida J, Thurlow S, Isaacson SH, Carvajal L, Rao J, Cook M, Hope-Porche C, McClurg L, Grasso DL, Logan R, Orme C, Ross T, Brocht AF, Constantinescu R, Sharma S, Venuto C, Weber J, Eaton K. PMID: 24366103.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    4. Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease. Mov Disord. 2013 Jun; 28(6):817-20. Factor SA, Wolski K, Togasaki DM, Huyck S, Cantillon M, Ho TW, Hauser RA, Pourcher E. PMID: 23589371.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCTClinical Trials
    5. Caffeine consumption and risk of dyskinesia in CALM-PD. Mov Disord. 2013 Mar; 28(3):380-3. Wills AM, Eberly S, Tennis M, Lang AE, Messing S, Togasaki D, Tanner CM, Kamp C, Chen JF, Oakes D, McDermott MP, Schwarzschild MA. PMID: 23339054.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    6. Memory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. Neurobiol Dis. 2008 Nov; 32(2):319-27. Vuckovic MG, Wood RI, Holschneider DP, Abernathy A, Togasaki DM, Smith A, Petzinger GM, Jakowec MW. PMID: 18718537.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsCells
    7. Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury. J Neurosci. 2007 May 16; 27(20):5291-300. Petzinger GM, Walsh JP, Akopian G, Hogg E, Abernathy A, Arevalo P, Turnquist P, Vuckovic M, Fisher BE, Togasaki DM, Jakowec MW. PMID: 17507552.
      View in: PubMed   Mentions: 93     Fields:    Translation:AnimalsCells
    8. The selective kappa-opioid receptor agonist U50,488 reduces L-dopa-induced dyskinesias but worsens parkinsonism in MPTP-treated primates. Exp Neurol. 2007 May; 205(1):101-7. Cox H, Togasaki DM, Chen L, Langston JW, Di Monte DA, Quik M. PMID: 17335811.
      View in: PubMed   Mentions: 8     Fields:    Translation:Animals
    9. The Webcam system: a simple, automated, computer-based video system for quantitative measurement of movement in nonhuman primates. J Neurosci Methods. 2005 Jun 30; 145(1-2):159-66. Togasaki DM, Hsu A, Samant M, Farzan B, DeLanney LE, Langston JW, Di Monte DA, Quik M. PMID: 15922034.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    10. Dyskinesias in normal squirrel monkeys induced by nomifensine and levodopa. Neuropharmacology. 2005 Mar; 48(3):398-405. Togasaki DM, Protell P, Tan LC, Langston JW, Di Monte DA, Quik M. PMID: 15721172.
      View in: PubMed   Mentions: 3     Fields:    Translation:Animals
    11. Enhanced striatal opioid receptor-mediated G-protein activation in L-DOPA-treated dyskinetic monkeys. Neuroscience. 2005; 132(2):409-20. Chen L, Togasaki DM, Langston JW, Di Monte DA, Quik M. PMID: 15802193.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    12. Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys. J Pharmacol Exp Ther. 2004 Nov; 311(2):770-7. Hsu A, Togasaki DM, Bezard E, Sokoloff P, Langston JW, Di Monte DA, Quik M. PMID: 15226382.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    13. The hyperkinetic abnormal movements scale: a tool for measuring levodopa-induced abnormal movements in squirrel monkeys. Mov Disord. 2002 Sep; 17(5):902-9. Tan LC, Protell PH, Langston JW, Togasaki DM. PMID: 12360538.
      View in: PubMed   Mentions: 9     Fields:    Translation:Animals
    14. Imaging and therapeutics: the role of neuronal transport in the regional specificity of L-DOPA accumulation in brain. Mol Imaging Biol. 2002 May; 4(3):208-18. Yee RE, Huang SC, Togasaki DM, Langston JW, Satyamurthy N, Barrio JR. PMID: 14537125.
      View in: PubMed   Mentions: 1     Fields:    
    15. Novel observations with FDOPA-PET imaging after early nigrostriatal damage. Mov Disord. 2001 Sep; 16(5):838-48. Yee RE, Irwin I, Milonas C, Stout DB, Huang SC, Shoghi-Jadid K, Satyamurthy N, Delanney LE, Togasaki DM, Farahani KF, Delfani K, Janson AM, Phelps ME, Langston JW, Barrio JR. PMID: 11746613.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    16. Levodopa induces dyskinesias in normal squirrel monkeys. Ann Neurol. 2001 Aug; 50(2):254-7. Togasaki DM, Tan L, Protell P, Di Monte DA, Quik M, Langston JW. PMID: 11506410.
      View in: PubMed   Mentions: 7     Fields:    Translation:Animals
    17. Epidemiologic aspects. Adv Neurol. 2000; 82:53-9. Togasaki DM, Tanner CM. PMID: 10624470.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    18. Effects of wild-type and mutated copper/zinc superoxide dismutase on neuronal survival and L-DOPA-induced toxicity in postnatal midbrain culture. J Neurochem. 1997 Jul; 69(1):21-33. Mena MA, Khan U, Togasaki DM, Sulzer D, Epstein CJ, Przedborski S. PMID: 9202290.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    19. Systemic and intrastriatal theophylline have opposite effects on dopamine and dopamine metabolites measured by intrastriatal microdialysis in the rat. Neurosci Lett. 1996 Apr 26; 208(3):159-62. Dethy S, Laute MA, Togasaki DM, Przedborski S, Damhaut P, Thiry P, Hildebrand J, Goldman S. PMID: 8733294.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    20. Neuroleptics up-regulate adenosine A2a receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia. J Neurochem. 1995 Nov; 65(5):2057-64. Parsons B, Togasaki DM, Kassir S, Przedborski S. PMID: 7595490.
      View in: PubMed   Mentions: 6     Fields:    Translation:AnimalsCells
    21. Dose-dependent lesions of the dopaminergic nigrostriatal pathway induced by intrastriatal injection of 6-hydroxydopamine. Neuroscience. 1995 Aug; 67(3):631-47. Przedborski S, Levivier M, Jiang H, Ferreira M, Jackson-Lewis V, Donaldson D, Togasaki DM. PMID: 7675192.
      View in: PubMed   Mentions: 72     Fields:    Translation:Animals
    22. Quantitative assessment of quinolinic acid-induced striatal toxicity in rats using radioligand binding assays. Neurol Res. 1994 Jun; 16(3):194-200. Levivier M, Holemans S, Togasaki DM, Maloteaux JM, Brotchi J, Przedborski S. PMID: 7936089.
      View in: PubMed   Mentions: 2     Fields:    Translation:AnimalsCells
    23. L-dihydroxyphenylalanine-induced asymmetric changes in striatal uric acid peak: determination by in vivo electrochemical detection in rats with unilateral nigrostriatal lesions. Life Sci. 1987 Sep 14; 41(11):1361-7. Togasaki DM, Young JG, Knott PJ. PMID: 3114581.
      View in: PubMed   Mentions:    Fields:    Translation:Animals
    24. Direct evidence of acute, massive striatal dopamine release in gerbils with unilateral strokes. Stroke. 1987 Jan-Feb; 18(1):108-10. Brannan T, Weinberger J, Knott P, Taff I, Kaufmann H, Togasaki D, Nieves-Rosa J, Maker H. PMID: 3810742.
      View in: PubMed   Mentions: 11     Fields:    Translation:Animals
    25. Caffeine stimulates beta-endorphin release in blood but not in cerebrospinal fluid. Life Sci. 1982 Sep 06; 31(10):1017-24. Arnold MA, Carr DB, Togasaki DM, Pian MC, Martin JB. PMID: 6290811.
      View in: PubMed   Mentions: 5     Fields:    Translation:Animals
    Daniel's Networks
    Concepts (168)
    Derived automatically from this person's publications.
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _